BioPharmX Corp fka BPMX

[Whos_Who]

BioPharmX's patents ensure a path to the the billion dollar market.

HYDROPHILIC TOPICAL SYSTEM
1 Patent Issued, 21 Pending

INJECTABLE SYSTEM
1 Patent Pending

ENCAPSULATION SYSTEM
3 Patents Issued, 4 Pending

How many companies here are ready for a real working product?

Olay (2013 brand value: $11.709 billion)
L’Oréal (2013 brand value: $8.696 billion)
Neutrogena (2013 brand value: $6.94 billion)
Nivea (2013 brand value: $5.843 billion)
Lancôme (2013 brand value: $5.508 billion)
Avon (2013 brand value: $5.169 billion)
Dove (2013 brand value: $4.242 billion)
Estée Lauder (2013 brand value: $3.87 billion)
Biore (2013 brand value: $3.378 billion)
Christian Dior (2013 brand value: $2.952 billion)
Pantene (2013 brand value: $2.91 billion
Chanel (2013 brand value: $2.813 billion)
Aveeno (2013 brand value: $2.793 billion)
Garnier (2013 brand value: $2.632 billion)
Schwarzkopf (2013 brand value: $2.42 billion
Maybelline (2013 brand value: $2.398 billion)
Clarins (2013 brand value: $2.375 billion)
Shiseido (2013 brand value: $2.203 billion)
Clean & Clear (2013 brand value: $2.196 billion)
Natura (2013 brand value: $1.849 billion)
L’Occitane (2013 brand value: $1.698 billion)
Johnson’s (2013 brand value: $1.513 billion)
Lux (2013 brand value: $1.501 billion)
MAC (2013 brand value: $1.382 billion)
Kérastase (2013 brand value: $1.36 billion)
Redken (2013 brand value: $1.285 billion)
Rexona (2013 brand value: $1.203 billion)
Biotherm (2013 brand value: $1.174 billion)
Vichy (2013 brand value: $1.17 billion)
Oriflame (2013 brand value: $1.151 billion)
Matrix (2013 brand value: $1.133 billion)
Clearasil (2013 brand value: $1.127 billion)

https://www.gcimagazine.com/marketstrends/segments/skincare/Brand-Valuation-Company-Releases-Listing-of-Most-Valuable-Cosmetic-Brands-202193961.html